Drug delivery companies develop technologies, formulations and platforms that control how, where and when therapeutic agents are released in the body. The field focuses on improving treatment efficacy, reducing side effects and helping medicines reach their intended targets safely and efficiently.
This category includes companies working on:
Browse 103 UK drug delivery companies below.
Global medical technology company specialising in chronic condition management
Convatec is a global medical products and technologies company focused on chronic condition management. The group develops and manufactures advanced wound care dressings, ostomy…
Engineered bacterial nanosyringes for intracellular protein delivery
NanoSyrinx is a discovery-stage biotechnology company developing a platform for targeted intracellular delivery of protein and peptide therapeutics. Based on naturally occurring…
Specialist renal pharmaceuticals and clinical nutrition products
Stanningley Pharma is a specialty pharmaceutical company focused on products for patients with chronic kidney disease and other hospital medicine therapeutic areas. The company…
AI-driven precision therapeutics for metabolic syndrome diseases
Multiomic Health is a data-centric therapeutics company developing precision medicines for metabolic syndrome-related conditions, including type 2 diabetes, cardiovascular…
MHRA-licensed manufacturer of unlicensed medicines and Specials
Arcadia Pharmaceuticals is a licensed contract manufacturer of unlicensed medicines, supplying Specials and Special Obtain products to NHS and pharmacy customers across the UK.…
Single-cell genomics and AI platform for autoimmune and fibrotic disease
Ensocell is a Cambridge-based biotechnology company developing precision biologics for autoimmune, inflammatory, and fibrotic diseases. Its platform integrates single-cell and…
Clinical-stage biopharma developing treatments for cancer and rare diseases
Biodexa Pharmaceuticals is a Cardiff-based clinical-stage biopharmaceutical company advancing a pipeline of proprietary drug formulations for diseases with high unmet need. Its…
Non-viral intracellular drug delivery for solid tumours
Vitarka Therapeutics is a preclinical biotech company developing a non-viral drug delivery platform for targeted intracellular delivery of therapeutics to solid tumours. The…
AI-enabled personalised dosing for drug-digital combination therapies
Closed Loop Medicine develops combination products integrating pharmaceutical therapies with AI-powered digital companions to personalise drug dosing for chronic conditions. Its…
Targeted oral drug delivery platform for cancer, CNS and respiratory disease
TRX Biosciences is a biotechnology company developing a targeted oral drug delivery platform, enabling therapies to reach specific organs, cells and tissues for cancer, central…
Formulation development CDMO for difficult pharmaceuticals
Agility Life Sciences is a contract development and manufacturing organisation specialising in pharmaceutical formulation development. Based in Stapleford, Nottingham, the company…
Clinical gamma scintigraphy for pharmaceutical formulation evaluation
Cardiff Scintigraphics is an independent contract research company specialising in gamma scintigraphy, a clinical imaging technique using radiolabelled drug formulations to…